{"name":"Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd","slug":"yangtze-river-pharmaceutical-group-jiangsu-zilong-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Levornidazole Disodium Phosphate for Injection","genericName":"Levornidazole Disodium Phosphate for Injection","slug":"levornidazole-disodium-phosphate-for-injection","indication":"Anaerobic bacterial infections","status":"marketed"},{"name":"Ornidazole and Sodium Chloride Injection","genericName":"Ornidazole and Sodium Chloride Injection","slug":"ornidazole-and-sodium-chloride-injection","indication":"Anaerobic bacterial infections","status":"marketed"}]}],"pipeline":[{"name":"Levornidazole Disodium Phosphate for Injection","genericName":"Levornidazole Disodium Phosphate for Injection","slug":"levornidazole-disodium-phosphate-for-injection","phase":"marketed","mechanism":"Levornidazole is a nitroimidazole antimicrobial that generates reactive oxygen species to damage DNA and disrupt cellular function in anaerobic microorganisms and certain parasites.","indications":["Anaerobic bacterial infections","Amebic dysentery and extraintestinal amebiasis","Trichomoniasis","Other protozoal and anaerobic infections"],"catalyst":""},{"name":"Ornidazole and Sodium Chloride Injection","genericName":"Ornidazole and Sodium Chloride Injection","slug":"ornidazole-and-sodium-chloride-injection","phase":"marketed","mechanism":"Ornidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group.","indications":["Anaerobic bacterial infections","Protozoal infections (e.g., trichomoniasis, amebiasis)","Surgical prophylaxis for anaerobic infection"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}